EGFR and hyperlipidemia: After adjusting for sex, age, BMI, hyperlipidemia, hypertension, diabetes, brain metastases, and radiotherapy, the EGFR‐TKI group had an almost 2.78‐fold higher relative risk of increased WMH load compared to non‐EGFR‐TKI.